世界のヒト用ワクチン販売市場レポート 2022年Global Human Vaccine Sales Market Report 2022 ワクチンとは、特定の疾患に対する能動的な獲得免疫を提供する生物学的製剤のことです。ワクチンは通常、病気を引き起こす微生物に類似した物質を含み、多くの場合、その微生物、その毒素、またはその表面タンパ... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーワクチンとは、特定の疾患に対する能動的な獲得免疫を提供する生物学的製剤のことです。ワクチンは通常、病気を引き起こす微生物に類似した物質を含み、多くの場合、その微生物、その毒素、またはその表面タンパク質の1つを弱めたもの、または殺したものから作られています。市場の分析と洞察ヒト用ワクチンの世界市場 COVID-19の大流行により、世界のヒト用ワクチンの市場規模は2021年に3億1950万米ドルと推定され、レビュー期間中にCAGR4.6%で2028年までに3億1950万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年にヒト用ワクチンの世界市場の%を占めたタイプ別は、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に修正された%のCAGRで成長すると予測されます。一方、タイプ別セグメントは、この予測期間を通して%CAGRに変更されています。 中国では、ヒト用ワクチンの主要なプレーヤーは、CNBG、Kangtai、ChengDaバイオなどがあります。世界の上位3社で約65%のシェアを占めています。 最大の市場は華東で、シェアは約25%、次いで華南、華北で、いずれもシェアは約40%となっています。 製品別では、B型肝炎が最も大きなセグメントで、約15%のシェアを占めています。また、用途別では、「小児」が最も多く、次いで「成人」となっています。 ヒト用ワクチンの世界市場範囲と市場規模 ヒト用ワクチンの世界市場は、企業別、地域(国)別、タイプ別、用途別に分類されています。世界のHuman Vaccine市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント分析では、2017年から2028年までの地域(国)別、タイプ別、用途別の売上、収益、予測に焦点を当てます。 タイプ別セグメント 水痘(みずぼうそう インフルエンザ ポリオ A型肝炎 狂犬病 BCG B型肝炎 百日せき、ジフテリア、破傷風 肺炎球菌 ロタワクチン 用途別セグメント 成人 小児 地域別 米国 欧州 中国 日本 東南アジア インド その他の地域 会社別 CNBG 長生人寿 Zhifei 成大生物 康泰 シノバクバイオテック ヒッセン ウォルバックスバイオテクノロジー GSK サノフィ ロンアン ヌオチェン・バイオ 花蘭バイオ 天壇バイオ 長春白柯 アディミューン 中塩柯バイオテック バーラト・バイオテック バイエルン・ノルディック サノフィパスツール インディアン・イミュノロジカルズ 康師傅 河南大生物製剤 中科生物製剤 卓義バイオ 目次1 Human Vaccine Market Overview1.1 Human Vaccine Product Scope 1.2 Human Vaccine Segment by Type 1.2.1 Global Human Vaccine Sales by Type (2017 & 2021 & 2028) 1.2.2 Varicella 1.2.3 Influenza 1.2.4 Polio 1.2.5 Hepatitis A 1.2.6 Rabies 1.2.7 BCG 1.2.8 Hepatitis B 1.2.9 Pertussis, Diphtheria, Tetanus 1.2.10 Pneumococcal 1.2.11 Rota vaccine 1.3 Human Vaccine Segment by Application 1.3.1 Global Human Vaccine Sales Comparison by Application (2017 & 2021 & 2028) 1.3.2 Adults 1.3.3 Children 1.4 Human Vaccine Market Estimates and Forecasts (2017-2028) 1.4.1 Global Human Vaccine Market Size in Value Growth Rate (2017-2028) 1.4.2 Global Human Vaccine Market Size in Volume Growth Rate (2017-2028) 1.4.3 Global Human Vaccine Price Trends (2017-2028) 2 Human Vaccine Estimates and Forecasts by Region 2.1 Global Human Vaccine Market Size by Region: 2017 VS 2021 VS 2028 2.2 Global Human Vaccine Retrospective Market Scenario by Region (2017-2022) 2.2.1 Global Human Vaccine Sales Market Share by Region (2017-2022) 2.2.2 Global Human Vaccine Revenue Market Share by Region (2017-2022) 2.3 Global Human Vaccine Market Estimates and Forecasts by Region (2023-2028) 2.3.1 Global Human Vaccine Sales Estimates and Forecasts by Region (2023-2028) 2.3.2 Global Human Vaccine Revenue Forecast by Region (2023-2028) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Human Vaccine Estimates and Projections (2017-2028) 2.4.2 Europe Human Vaccine Estimates and Projections (2017-2028) 2.4.3 China Human Vaccine Estimates and Projections (2017-2028) 2.4.4 Japan Human Vaccine Estimates and Projections (2017-2028) 2.4.5 Southeast Asia Human Vaccine Estimates and Projections (2017-2028) 2.4.6 India Human Vaccine Estimates and Projections (2017-2028) 3 Global Human Vaccine Competition Landscape by Players 3.1 Global Top Human Vaccine Players by Sales (2017-2022) 3.2 Global Top Human Vaccine Players by Revenue (2017-2022) 3.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2021) 3.4 Global Human Vaccine Average Price by Company (2017-2022) 3.5 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Human Vaccine Market Size by Type 4.1 Global Human Vaccine Historic Market Review by Type (2017-2022) 4.1.1 Global Human Vaccine Sales Market Share by Type (2017-2022) 4.1.2 Global Human Vaccine Revenue Market Share by Type (2017-2022) 4.1.3 Global Human Vaccine Price by Type (2017-2022) 4.2 Global Human Vaccine Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Human Vaccine Sales Forecast by Type (2023-2028) 4.2.2 Global Human Vaccine Revenue Forecast by Type (2023-2028) 4.2.3 Global Human Vaccine Price Forecast by Type (2023-2028) 5 Global Human Vaccine Market Size by Application 5.1 Global Human Vaccine Historic Market Review by Application (2017-2022) 5.1.1 Global Human Vaccine Sales Market Share by Application (2017-2022) 5.1.2 Global Human Vaccine Revenue Market Share by Application (2017-2022) 5.1.3 Global Human Vaccine Price by Application (2017-2022) 5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Human Vaccine Sales Forecast by Application (2023-2028) 5.2.2 Global Human Vaccine Revenue Forecast by Application (2023-2028) 5.2.3 Global Human Vaccine Price Forecast by Application (2023-2028) 6 United States Human Vaccine Market Facts & Figures 6.1 United States Human Vaccine Sales by Company 6.1.1 United States Human Vaccine Sales by Company (2017-2022) 6.1.2 United States Human Vaccine Revenue by Company (2017-2022) 6.2 United States Human Vaccine Sales Breakdown by Type 6.2.1 United States Human Vaccine Sales Breakdown by Type (2017-2022) 6.2.2 United States Human Vaccine Sales Breakdown by Type (2023-2028) 6.3 United States Human Vaccine Sales Breakdown by Application 6.3.1 United States Human Vaccine Sales Breakdown by Application (2017-2022) 6.3.2 United States Human Vaccine Sales Breakdown by Application (2023-2028) 7 Europe Human Vaccine Market Facts & Figures 7.1 Europe Human Vaccine Sales by Company 7.1.1 Europe Human Vaccine Sales by Company (2017-2022) 7.1.2 Europe Human Vaccine Revenue by Company (2017-2022) 7.2 Europe Human Vaccine Sales Breakdown by Type 7.2.1 Europe Human Vaccine Sales Breakdown by Type (2017-2022) 7.2.2 Europe Human Vaccine Sales Breakdown by Type (2023-2028) 7.3 Europe Human Vaccine Sales Breakdown by Application 7.3.1 Europe Human Vaccine Sales Breakdown by Application (2017-2022) 7.3.2 Europe Human Vaccine Sales Breakdown by Application (2023-2028) 8 China Human Vaccine Market Facts & Figures 8.1 China Human Vaccine Sales by Company 8.1.1 China Human Vaccine Sales by Company (2017-2022) 8.1.2 China Human Vaccine Revenue by Company (2017-2022) 8.2 China Human Vaccine Sales Breakdown by Type 8.2.1 China Human Vaccine Sales Breakdown by Type (2017-2022) 8.2.2 China Human Vaccine Sales Breakdown by Type (2023-2028) 8.3 China Human Vaccine Sales Breakdown by Application 8.3.1 China Human Vaccine Sales Breakdown by Application (2017-2022) 8.3.2 China Human Vaccine Sales Breakdown by Application (2023-2028) 9 Japan Human Vaccine Market Facts & Figures 9.1 Japan Human Vaccine Sales by Company 9.1.1 Japan Human Vaccine Sales by Company (2017-2022) 9.1.2 Japan Human Vaccine Revenue by Company (2017-2022) 9.2 Japan Human Vaccine Sales Breakdown by Type 9.2.1 Japan Human Vaccine Sales Breakdown by Type (2017-2022) 9.2.2 Japan Human Vaccine Sales Breakdown by Type (2023-2028) 9.3 Japan Human Vaccine Sales Breakdown by Application 9.3.1 Japan Human Vaccine Sales Breakdown by Application (2017-2022) 9.3.2 Japan Human Vaccine Sales Breakdown by Application (2023-2028) 10 Southeast Asia Human Vaccine Market Facts & Figures 10.1 Southeast Asia Human Vaccine Sales by Company 10.1.1 Southeast Asia Human Vaccine Sales by Company (2017-2022) 10.1.2 Southeast Asia Human Vaccine Revenue by Company (2017-2022) 10.2 Southeast Asia Human Vaccine Sales Breakdown by Type 10.2.1 Southeast Asia Human Vaccine Sales Breakdown by Type (2017-2022) 10.2.2 Southeast Asia Human Vaccine Sales Breakdown by Type (2023-2028) 10.3 Southeast Asia Human Vaccine Sales Breakdown by Application 10.3.1 Southeast Asia Human Vaccine Sales Breakdown by Application (2017-2022) 10.3.2 Southeast Asia Human Vaccine Sales Breakdown by Application (2023-2028) 11 India Human Vaccine Market Facts & Figures 11.1 India Human Vaccine Sales by Company 11.1.1 India Human Vaccine Sales by Company (2017-2022) 11.1.2 India Human Vaccine Revenue by Company (2017-2022) 11.2 India Human Vaccine Sales Breakdown by Type 11.2.1 India Human Vaccine Sales Breakdown by Type (2017-2022) 11.2.2 India Human Vaccine Sales Breakdown by Type (2023-2028) 11.3 India Human Vaccine Sales Breakdown by Application 11.3.1 India Human Vaccine Sales Breakdown by Application (2017-2022) 11.3.2 India Human Vaccine Sales Breakdown by Application (2023-2028) 12 Company Profiles and Key Figures in Human Vaccine Business 12.1 CNBG 12.1.1 CNBG Corporation Information 12.1.2 CNBG Business Overview 12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.1.4 CNBG Human Vaccine Products Offered 12.1.5 CNBG Recent Development 12.2 Changsheng Life 12.2.1 Changsheng Life Corporation Information 12.2.2 Changsheng Life Business Overview 12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.2.4 Changsheng Life Human Vaccine Products Offered 12.2.5 Changsheng Life Recent Development 12.3 Zhifei 12.3.1 Zhifei Corporation Information 12.3.2 Zhifei Business Overview 12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.3.4 Zhifei Human Vaccine Products Offered 12.3.5 Zhifei Recent Development 12.4 ChengDa Bio 12.4.1 ChengDa Bio Corporation Information 12.4.2 ChengDa Bio Business Overview 12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.4.4 ChengDa Bio Human Vaccine Products Offered 12.4.5 ChengDa Bio Recent Development 12.5 Kangtai 12.5.1 Kangtai Corporation Information 12.5.2 Kangtai Business Overview 12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.5.4 Kangtai Human Vaccine Products Offered 12.5.5 Kangtai Recent Development 12.6 SINOVAC BIOTECH 12.6.1 SINOVAC BIOTECH Corporation Information 12.6.2 SINOVAC BIOTECH Business Overview 12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered 12.6.5 SINOVAC BIOTECH Recent Development 12.7 Hissen 12.7.1 Hissen Corporation Information 12.7.2 Hissen Business Overview 12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.7.4 Hissen Human Vaccine Products Offered 12.7.5 Hissen Recent Development 12.8 Walvax Biotechnology 12.8.1 Walvax Biotechnology Corporation Information 12.8.2 Walvax Biotechnology Business Overview 12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.8.4 Walvax Biotechnology Human Vaccine Products Offered 12.8.5 Walvax Biotechnology Recent Development 12.9 GSK 12.9.1 GSK Corporation Information 12.9.2 GSK Business Overview 12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.9.4 GSK Human Vaccine Products Offered 12.9.5 GSK Recent Development 12.10 SANOFI 12.10.1 SANOFI Corporation Information 12.10.2 SANOFI Business Overview 12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.10.4 SANOFI Human Vaccine Products Offered 12.10.5 SANOFI Recent Development 12.11 Rong An 12.11.1 Rong An Corporation Information 12.11.2 Rong An Business Overview 12.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.11.4 Rong An Human Vaccine Products Offered 12.11.5 Rong An Recent Development 12.12 NuoCheng Bio 12.12.1 NuoCheng Bio Corporation Information 12.12.2 NuoCheng Bio Business Overview 12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.12.4 NuoCheng Bio Human Vaccine Products Offered 12.12.5 NuoCheng Bio Recent Development 12.13 Hualan Bio 12.13.1 Hualan Bio Corporation Information 12.13.2 Hualan Bio Business Overview 12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.13.4 Hualan Bio Human Vaccine Products Offered 12.13.5 Hualan Bio Recent Development 12.14 Tiantan biological 12.14.1 Tiantan biological Corporation Information 12.14.2 Tiantan biological Business Overview 12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.14.4 Tiantan biological Human Vaccine Products Offered 12.14.5 Tiantan biological Recent Development 12.15 Changchun Baike 12.15.1 Changchun Baike Corporation Information 12.15.2 Changchun Baike Business Overview 12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.15.4 Changchun Baike Human Vaccine Products Offered 12.15.5 Changchun Baike Recent Development 12.16 Adimmune 12.16.1 Adimmune Corporation Information 12.16.2 Adimmune Business Overview 12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.16.4 Adimmune Human Vaccine Products Offered 12.16.5 Adimmune Recent Development 12.17 Zhongyianke Biotech 12.17.1 Zhongyianke Biotech Corporation Information 12.17.2 Zhongyianke Biotech Business Overview 12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.17.4 Zhongyianke Biotech Human Vaccine Products Offered 12.17.5 Zhongyianke Biotech Recent Development 12.18 Bharat Biotech 12.18.1 Bharat Biotech Corporation Information 12.18.2 Bharat Biotech Business Overview 12.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.18.4 Bharat Biotech Human Vaccine Products Offered 12.18.5 Bharat Biotech Recent Development 12.19 Bavarian Nordic 12.19.1 Bavarian Nordic Corporation Information 12.19.2 Bavarian Nordic Business Overview 12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.19.4 Bavarian Nordic Human Vaccine Products Offered 12.19.5 Bavarian Nordic Recent Development 12.20 Sanofi-Pasteur 12.20.1 Sanofi-Pasteur Corporation Information 12.20.2 Sanofi-Pasteur Business Overview 12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.20.4 Sanofi-Pasteur Human Vaccine Products Offered 12.20.5 Sanofi-Pasteur Recent Development 12.21 Indian Immunologicals 12.21.1 Indian Immunologicals Corporation Information 12.21.2 Indian Immunologicals Business Overview 12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.21.4 Indian Immunologicals Human Vaccine Products Offered 12.21.5 Indian Immunologicals Recent Development 12.22 KANGH 12.22.1 KANGH Corporation Information 12.22.2 KANGH Business Overview 12.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.22.4 KANGH Human Vaccine Products Offered 12.22.5 KANGH Recent Development 12.23 Henan Grand Biopharma 12.23.1 Henan Grand Biopharma Corporation Information 12.23.2 Henan Grand Biopharma Business Overview 12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.23.4 Henan Grand Biopharma Human Vaccine Products Offered 12.23.5 Henan Grand Biopharma Recent Development 12.24 ZhongKe Biopharm 12.24.1 ZhongKe Biopharm Corporation Information 12.24.2 ZhongKe Biopharm Business Overview 12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.24.4 ZhongKe Biopharm Human Vaccine Products Offered 12.24.5 ZhongKe Biopharm Recent Development 12.25 Zhuoyi Biological 12.25.1 Zhuoyi Biological Corporation Information 12.25.2 Zhuoyi Biological Business Overview 12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.25.4 Zhuoyi Biological Human Vaccine Products Offered 12.25.5 Zhuoyi Biological Recent Development 13 Human Vaccine Manufacturing Cost Analysis 13.1 Human Vaccine Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Human Vaccine 13.4 Human Vaccine Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Human Vaccine Distributors List 14.3 Human Vaccine Customers 15 Market Dynamics 15.1 Human Vaccine Industry Trends 15.2 Human Vaccine Market Drivers 15.3 Human Vaccine Market Challenges 15.4 Human Vaccine Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer
SummaryA vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Table of Contents1 Human Vaccine Market Overview1.1 Human Vaccine Product Scope 1.2 Human Vaccine Segment by Type 1.2.1 Global Human Vaccine Sales by Type (2017 & 2021 & 2028) 1.2.2 Varicella 1.2.3 Influenza 1.2.4 Polio 1.2.5 Hepatitis A 1.2.6 Rabies 1.2.7 BCG 1.2.8 Hepatitis B 1.2.9 Pertussis, Diphtheria, Tetanus 1.2.10 Pneumococcal 1.2.11 Rota vaccine 1.3 Human Vaccine Segment by Application 1.3.1 Global Human Vaccine Sales Comparison by Application (2017 & 2021 & 2028) 1.3.2 Adults 1.3.3 Children 1.4 Human Vaccine Market Estimates and Forecasts (2017-2028) 1.4.1 Global Human Vaccine Market Size in Value Growth Rate (2017-2028) 1.4.2 Global Human Vaccine Market Size in Volume Growth Rate (2017-2028) 1.4.3 Global Human Vaccine Price Trends (2017-2028) 2 Human Vaccine Estimates and Forecasts by Region 2.1 Global Human Vaccine Market Size by Region: 2017 VS 2021 VS 2028 2.2 Global Human Vaccine Retrospective Market Scenario by Region (2017-2022) 2.2.1 Global Human Vaccine Sales Market Share by Region (2017-2022) 2.2.2 Global Human Vaccine Revenue Market Share by Region (2017-2022) 2.3 Global Human Vaccine Market Estimates and Forecasts by Region (2023-2028) 2.3.1 Global Human Vaccine Sales Estimates and Forecasts by Region (2023-2028) 2.3.2 Global Human Vaccine Revenue Forecast by Region (2023-2028) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Human Vaccine Estimates and Projections (2017-2028) 2.4.2 Europe Human Vaccine Estimates and Projections (2017-2028) 2.4.3 China Human Vaccine Estimates and Projections (2017-2028) 2.4.4 Japan Human Vaccine Estimates and Projections (2017-2028) 2.4.5 Southeast Asia Human Vaccine Estimates and Projections (2017-2028) 2.4.6 India Human Vaccine Estimates and Projections (2017-2028) 3 Global Human Vaccine Competition Landscape by Players 3.1 Global Top Human Vaccine Players by Sales (2017-2022) 3.2 Global Top Human Vaccine Players by Revenue (2017-2022) 3.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2021) 3.4 Global Human Vaccine Average Price by Company (2017-2022) 3.5 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Human Vaccine Market Size by Type 4.1 Global Human Vaccine Historic Market Review by Type (2017-2022) 4.1.1 Global Human Vaccine Sales Market Share by Type (2017-2022) 4.1.2 Global Human Vaccine Revenue Market Share by Type (2017-2022) 4.1.3 Global Human Vaccine Price by Type (2017-2022) 4.2 Global Human Vaccine Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Human Vaccine Sales Forecast by Type (2023-2028) 4.2.2 Global Human Vaccine Revenue Forecast by Type (2023-2028) 4.2.3 Global Human Vaccine Price Forecast by Type (2023-2028) 5 Global Human Vaccine Market Size by Application 5.1 Global Human Vaccine Historic Market Review by Application (2017-2022) 5.1.1 Global Human Vaccine Sales Market Share by Application (2017-2022) 5.1.2 Global Human Vaccine Revenue Market Share by Application (2017-2022) 5.1.3 Global Human Vaccine Price by Application (2017-2022) 5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Human Vaccine Sales Forecast by Application (2023-2028) 5.2.2 Global Human Vaccine Revenue Forecast by Application (2023-2028) 5.2.3 Global Human Vaccine Price Forecast by Application (2023-2028) 6 United States Human Vaccine Market Facts & Figures 6.1 United States Human Vaccine Sales by Company 6.1.1 United States Human Vaccine Sales by Company (2017-2022) 6.1.2 United States Human Vaccine Revenue by Company (2017-2022) 6.2 United States Human Vaccine Sales Breakdown by Type 6.2.1 United States Human Vaccine Sales Breakdown by Type (2017-2022) 6.2.2 United States Human Vaccine Sales Breakdown by Type (2023-2028) 6.3 United States Human Vaccine Sales Breakdown by Application 6.3.1 United States Human Vaccine Sales Breakdown by Application (2017-2022) 6.3.2 United States Human Vaccine Sales Breakdown by Application (2023-2028) 7 Europe Human Vaccine Market Facts & Figures 7.1 Europe Human Vaccine Sales by Company 7.1.1 Europe Human Vaccine Sales by Company (2017-2022) 7.1.2 Europe Human Vaccine Revenue by Company (2017-2022) 7.2 Europe Human Vaccine Sales Breakdown by Type 7.2.1 Europe Human Vaccine Sales Breakdown by Type (2017-2022) 7.2.2 Europe Human Vaccine Sales Breakdown by Type (2023-2028) 7.3 Europe Human Vaccine Sales Breakdown by Application 7.3.1 Europe Human Vaccine Sales Breakdown by Application (2017-2022) 7.3.2 Europe Human Vaccine Sales Breakdown by Application (2023-2028) 8 China Human Vaccine Market Facts & Figures 8.1 China Human Vaccine Sales by Company 8.1.1 China Human Vaccine Sales by Company (2017-2022) 8.1.2 China Human Vaccine Revenue by Company (2017-2022) 8.2 China Human Vaccine Sales Breakdown by Type 8.2.1 China Human Vaccine Sales Breakdown by Type (2017-2022) 8.2.2 China Human Vaccine Sales Breakdown by Type (2023-2028) 8.3 China Human Vaccine Sales Breakdown by Application 8.3.1 China Human Vaccine Sales Breakdown by Application (2017-2022) 8.3.2 China Human Vaccine Sales Breakdown by Application (2023-2028) 9 Japan Human Vaccine Market Facts & Figures 9.1 Japan Human Vaccine Sales by Company 9.1.1 Japan Human Vaccine Sales by Company (2017-2022) 9.1.2 Japan Human Vaccine Revenue by Company (2017-2022) 9.2 Japan Human Vaccine Sales Breakdown by Type 9.2.1 Japan Human Vaccine Sales Breakdown by Type (2017-2022) 9.2.2 Japan Human Vaccine Sales Breakdown by Type (2023-2028) 9.3 Japan Human Vaccine Sales Breakdown by Application 9.3.1 Japan Human Vaccine Sales Breakdown by Application (2017-2022) 9.3.2 Japan Human Vaccine Sales Breakdown by Application (2023-2028) 10 Southeast Asia Human Vaccine Market Facts & Figures 10.1 Southeast Asia Human Vaccine Sales by Company 10.1.1 Southeast Asia Human Vaccine Sales by Company (2017-2022) 10.1.2 Southeast Asia Human Vaccine Revenue by Company (2017-2022) 10.2 Southeast Asia Human Vaccine Sales Breakdown by Type 10.2.1 Southeast Asia Human Vaccine Sales Breakdown by Type (2017-2022) 10.2.2 Southeast Asia Human Vaccine Sales Breakdown by Type (2023-2028) 10.3 Southeast Asia Human Vaccine Sales Breakdown by Application 10.3.1 Southeast Asia Human Vaccine Sales Breakdown by Application (2017-2022) 10.3.2 Southeast Asia Human Vaccine Sales Breakdown by Application (2023-2028) 11 India Human Vaccine Market Facts & Figures 11.1 India Human Vaccine Sales by Company 11.1.1 India Human Vaccine Sales by Company (2017-2022) 11.1.2 India Human Vaccine Revenue by Company (2017-2022) 11.2 India Human Vaccine Sales Breakdown by Type 11.2.1 India Human Vaccine Sales Breakdown by Type (2017-2022) 11.2.2 India Human Vaccine Sales Breakdown by Type (2023-2028) 11.3 India Human Vaccine Sales Breakdown by Application 11.3.1 India Human Vaccine Sales Breakdown by Application (2017-2022) 11.3.2 India Human Vaccine Sales Breakdown by Application (2023-2028) 12 Company Profiles and Key Figures in Human Vaccine Business 12.1 CNBG 12.1.1 CNBG Corporation Information 12.1.2 CNBG Business Overview 12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.1.4 CNBG Human Vaccine Products Offered 12.1.5 CNBG Recent Development 12.2 Changsheng Life 12.2.1 Changsheng Life Corporation Information 12.2.2 Changsheng Life Business Overview 12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.2.4 Changsheng Life Human Vaccine Products Offered 12.2.5 Changsheng Life Recent Development 12.3 Zhifei 12.3.1 Zhifei Corporation Information 12.3.2 Zhifei Business Overview 12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.3.4 Zhifei Human Vaccine Products Offered 12.3.5 Zhifei Recent Development 12.4 ChengDa Bio 12.4.1 ChengDa Bio Corporation Information 12.4.2 ChengDa Bio Business Overview 12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.4.4 ChengDa Bio Human Vaccine Products Offered 12.4.5 ChengDa Bio Recent Development 12.5 Kangtai 12.5.1 Kangtai Corporation Information 12.5.2 Kangtai Business Overview 12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.5.4 Kangtai Human Vaccine Products Offered 12.5.5 Kangtai Recent Development 12.6 SINOVAC BIOTECH 12.6.1 SINOVAC BIOTECH Corporation Information 12.6.2 SINOVAC BIOTECH Business Overview 12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered 12.6.5 SINOVAC BIOTECH Recent Development 12.7 Hissen 12.7.1 Hissen Corporation Information 12.7.2 Hissen Business Overview 12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.7.4 Hissen Human Vaccine Products Offered 12.7.5 Hissen Recent Development 12.8 Walvax Biotechnology 12.8.1 Walvax Biotechnology Corporation Information 12.8.2 Walvax Biotechnology Business Overview 12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.8.4 Walvax Biotechnology Human Vaccine Products Offered 12.8.5 Walvax Biotechnology Recent Development 12.9 GSK 12.9.1 GSK Corporation Information 12.9.2 GSK Business Overview 12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.9.4 GSK Human Vaccine Products Offered 12.9.5 GSK Recent Development 12.10 SANOFI 12.10.1 SANOFI Corporation Information 12.10.2 SANOFI Business Overview 12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.10.4 SANOFI Human Vaccine Products Offered 12.10.5 SANOFI Recent Development 12.11 Rong An 12.11.1 Rong An Corporation Information 12.11.2 Rong An Business Overview 12.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.11.4 Rong An Human Vaccine Products Offered 12.11.5 Rong An Recent Development 12.12 NuoCheng Bio 12.12.1 NuoCheng Bio Corporation Information 12.12.2 NuoCheng Bio Business Overview 12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.12.4 NuoCheng Bio Human Vaccine Products Offered 12.12.5 NuoCheng Bio Recent Development 12.13 Hualan Bio 12.13.1 Hualan Bio Corporation Information 12.13.2 Hualan Bio Business Overview 12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.13.4 Hualan Bio Human Vaccine Products Offered 12.13.5 Hualan Bio Recent Development 12.14 Tiantan biological 12.14.1 Tiantan biological Corporation Information 12.14.2 Tiantan biological Business Overview 12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.14.4 Tiantan biological Human Vaccine Products Offered 12.14.5 Tiantan biological Recent Development 12.15 Changchun Baike 12.15.1 Changchun Baike Corporation Information 12.15.2 Changchun Baike Business Overview 12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.15.4 Changchun Baike Human Vaccine Products Offered 12.15.5 Changchun Baike Recent Development 12.16 Adimmune 12.16.1 Adimmune Corporation Information 12.16.2 Adimmune Business Overview 12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.16.4 Adimmune Human Vaccine Products Offered 12.16.5 Adimmune Recent Development 12.17 Zhongyianke Biotech 12.17.1 Zhongyianke Biotech Corporation Information 12.17.2 Zhongyianke Biotech Business Overview 12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.17.4 Zhongyianke Biotech Human Vaccine Products Offered 12.17.5 Zhongyianke Biotech Recent Development 12.18 Bharat Biotech 12.18.1 Bharat Biotech Corporation Information 12.18.2 Bharat Biotech Business Overview 12.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.18.4 Bharat Biotech Human Vaccine Products Offered 12.18.5 Bharat Biotech Recent Development 12.19 Bavarian Nordic 12.19.1 Bavarian Nordic Corporation Information 12.19.2 Bavarian Nordic Business Overview 12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.19.4 Bavarian Nordic Human Vaccine Products Offered 12.19.5 Bavarian Nordic Recent Development 12.20 Sanofi-Pasteur 12.20.1 Sanofi-Pasteur Corporation Information 12.20.2 Sanofi-Pasteur Business Overview 12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.20.4 Sanofi-Pasteur Human Vaccine Products Offered 12.20.5 Sanofi-Pasteur Recent Development 12.21 Indian Immunologicals 12.21.1 Indian Immunologicals Corporation Information 12.21.2 Indian Immunologicals Business Overview 12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.21.4 Indian Immunologicals Human Vaccine Products Offered 12.21.5 Indian Immunologicals Recent Development 12.22 KANGH 12.22.1 KANGH Corporation Information 12.22.2 KANGH Business Overview 12.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.22.4 KANGH Human Vaccine Products Offered 12.22.5 KANGH Recent Development 12.23 Henan Grand Biopharma 12.23.1 Henan Grand Biopharma Corporation Information 12.23.2 Henan Grand Biopharma Business Overview 12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.23.4 Henan Grand Biopharma Human Vaccine Products Offered 12.23.5 Henan Grand Biopharma Recent Development 12.24 ZhongKe Biopharm 12.24.1 ZhongKe Biopharm Corporation Information 12.24.2 ZhongKe Biopharm Business Overview 12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.24.4 ZhongKe Biopharm Human Vaccine Products Offered 12.24.5 ZhongKe Biopharm Recent Development 12.25 Zhuoyi Biological 12.25.1 Zhuoyi Biological Corporation Information 12.25.2 Zhuoyi Biological Business Overview 12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022) 12.25.4 Zhuoyi Biological Human Vaccine Products Offered 12.25.5 Zhuoyi Biological Recent Development 13 Human Vaccine Manufacturing Cost Analysis 13.1 Human Vaccine Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Human Vaccine 13.4 Human Vaccine Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Human Vaccine Distributors List 14.3 Human Vaccine Customers 15 Market Dynamics 15.1 Human Vaccine Industry Trends 15.2 Human Vaccine Market Drivers 15.3 Human Vaccine Market Challenges 15.4 Human Vaccine Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗生物薬)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(vaccine)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |